People In Brief: Sanofi Chief Patient Officer, New Leaders At DSM, NAI And KonaRed
This article was originally published in The Tan Sheet
Sanofi appoints chief patient officer; DSM names new leaders; marketing VP leaves Immunotec; Nutrition Zone names president; NAI names VP global sales; Kyowa Hakko USA hires sales manager; KonaRed appoints CFO, board member; Deloitte adds director of research.
You may also be interested in...
Gilead and Arcus believe their ‘Fc silent’ TIGIT inhibitor candidate could be best in class, but analysts think only outstanding results in lung cancer will sway investor sentiment.
The UK major has been building its cell therapy portfolio for about three years internally, oncology R&D chief Susan Galbraith tells Scrip, and the purchase of Neogene and its TCR-Ts targeting neoantigens in solid cancers is a logical step.
Are too few digital health care apps approved for reimbursement in Germany? That’s not the point, says the health care ministry, urging a look at the bigger strategic picture.